Cargando…

Blocking Type I Interferon Production: A New Therapeutic Option to Reduce the HIV-1-Induced Immune Activation

Highly active antiretroviral therapy has dramatically improved the morbidity and mortality of HIV-1-infected individuals. A total of 25 licensed drugs provide the basis for an optimized virus-suppressive treatment of nearly each subject. The promises of immune reconstitution and normal life expectan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ries, Moritz, Pritschet, Kathrin, Schmidt, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235520/
https://www.ncbi.nlm.nih.gov/pubmed/22203858
http://dx.doi.org/10.1155/2012/534929